Trending...
- Suburban Orthopaedics Expands Spine Team with Board-Certified Surgeon Joseph Brindise, DO
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- Naperville: Drive Sober or Get Pulled Over This Season
CHICAGO, June 18, 2021 /PRNewswire/ -- Registration and abstract submissions are now being accepted for the International Workshop on Chronic Lymphocytic Leukemia (iwCLL), which will occur virtually, 16-20 September 2021. In the interest of the health and safety of attendees, the organizing committee decided to proceed with the conference in a virtual format.
"The virtual format of this conference allows us to innovate. Because all of the content will be accessible to attendees via live streams and recordings, we will be able to deliver this vital information to even more physicians and clinicians from around the globe," said Tadeusz Robak, MD PhD.
The iwCLL biennial international conference, professionally organized by Bio Ascend, will feature 41 faculty experts in CLL from around the world, thought-provoking discussions, debates, and virtual networking focusing on three main themes: Pathogenesis of CLL, Approach Considerations and Treatment Options in CLL, and Rationally Designed Therapy on the Horizon in CLL. The final deadline for abstract submissions is 30 June, and while registration for the conference closes on 10 September, attendees must be registered before 30 June to receive the discounted registration fees. In addition, Young Investigators are invited to participate in the Young Investigator meeting 16 September.
More on illi News
Rate categories include pricing for physicians, allied health professionals, patient advocates, fellows/residents, and other industry professionals. Discount rates are available for Young Investigators, defined as any physician or scientist presently in a residency, fellowship, or doctoral training program, or who has been in such a program in the last ten years. This rate also applies to graduate or medical school students working toward a career in hematology or oncology research.
For more information on the conference or to register, visit iwcll2021.org.
About Bio Ascend:
Bio Ascend is an independent medical education company committed to supporting health care providers in their efforts to translate innovative science into clinical practice. The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components. The team has extensive experience in planning, executing, and assessing meaningful education for clinicians.
More on illi News
About iwCLL:
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts – from laboratory-based research to the clinic – in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for four days every other year.
SOURCE Bio Ascend
"The virtual format of this conference allows us to innovate. Because all of the content will be accessible to attendees via live streams and recordings, we will be able to deliver this vital information to even more physicians and clinicians from around the globe," said Tadeusz Robak, MD PhD.
The iwCLL biennial international conference, professionally organized by Bio Ascend, will feature 41 faculty experts in CLL from around the world, thought-provoking discussions, debates, and virtual networking focusing on three main themes: Pathogenesis of CLL, Approach Considerations and Treatment Options in CLL, and Rationally Designed Therapy on the Horizon in CLL. The final deadline for abstract submissions is 30 June, and while registration for the conference closes on 10 September, attendees must be registered before 30 June to receive the discounted registration fees. In addition, Young Investigators are invited to participate in the Young Investigator meeting 16 September.
More on illi News
- Digi 995 Unveils New Official Website and Shop, Expanding the Digiverse
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
Rate categories include pricing for physicians, allied health professionals, patient advocates, fellows/residents, and other industry professionals. Discount rates are available for Young Investigators, defined as any physician or scientist presently in a residency, fellowship, or doctoral training program, or who has been in such a program in the last ten years. This rate also applies to graduate or medical school students working toward a career in hematology or oncology research.
For more information on the conference or to register, visit iwcll2021.org.
About Bio Ascend:
Bio Ascend is an independent medical education company committed to supporting health care providers in their efforts to translate innovative science into clinical practice. The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components. The team has extensive experience in planning, executing, and assessing meaningful education for clinicians.
More on illi News
- The City of Chicago Will Ring in the New Year with Fireworks on the Chicago River and at Navy Pier Wednesday, December 31
- City of Chicago Shares Key Logistical, Safety Information for Upcoming New Year's Eve Celebration
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
- TRIO Heating, Air & Plumbing Now Ranks #1 in San Jose
About iwCLL:
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts – from laboratory-based research to the clinic – in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for four days every other year.
SOURCE Bio Ascend
Filed Under: Business
0 Comments
Latest on illi News
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
- Bent Danholm Joins The American Dream TV as Central Florida Host
- Tickeron Unveils AI-Powered Trading Insights Aligned with Key Monthly Consumer Data
- 360Massage Launches Custom-Built Massage Chairs Designed to Match Modern Homes
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- City of Naperville Launches New and Improved eBill Portal
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- Holiday Pond Lighting Ideas for Chicago-Area Water Features
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels
- UK Financial Ltd Sets Official 30-Day Conversion Deadline for Three Exchange Listed Tokens Ahead of Regulated Upgrade
- New Jersey Therapy and Life Coaching Unveils Original Dan Fenelon Mural in Voorhees New Jersey Therapy Office
- Illinois 45th District Candidate Josh Atkinson Introduces a New Way to Reach Voters
- Kentucky Judges Ignore Evidence, Prolong Father's Ordeal in Baseless Case